Skip to main content
. 2021 Jul 2;13(13):3335. doi: 10.3390/cancers13133335

Table 2.

Immunohistochemical findings.

Parameter n, %
CD20 (n = 73)
Low (score 0–1) 65, 89%
High (score 2–3) 8, 11%
CD8 (n = 81)
Low (score 0–1) 55, 67.9%
High (score 2–3) 26, 32.1%
CD4 (n = 41)
Low (score 0–1) 25, 61%
High (score 2–3) 16, 39%
CD163 (n = 74)
Low (score 0–1) 45, 60.8%
High (score 2–3) 29, 39.2%
PD-L1 inflammatory cells (n = 81)
No (score 0) 60, 74%
Yes (score 1–3) 21, 26%
CD34 vascular density (n = 74)
Range 1–22
Median (High and Low, n,%) 3.5 (37, 50% and 37, 50%)
Mean ± SD 5.8 ± 5.7
MECA-79 vessels (n = 59)
High 5, 8.5%
Low 54, 91.5%